Posted On: 08/09/2013 1:02:22 PM
Post# of 5066
Re: patientgal #2286
Pg, the stock has dropped from its high to where it is now because the hype of FDA approval never materialized. It was the classic pump on the hope of FDA approval and then the dump when it didn't happen. But I will agree with you that there are a lot of ignorant people who have poor reading comprehension issues. Many thought the PR with the FDA giving BMSN a FDA IND submission number was FDA approval. I told them on IHUB board that they were sadly mistaken only to have my comments deleted due to the fact that the IHUB board isn't a place for rational discussion,just hype.
Again, BMSN's destiny is based on what the FDA decides not on what posters on a message board say and do.
If there is any manipulation of BMSN, which I agree can easily be done due to it being a penny stock, it's been clearly focused on the range i previously mentioned.
Until then we wait for the FDA decision to either give credibility to the science you believe in or to further erode BMSN's PPS into bankruptcy if it can't recover from FDA denial.
I think we both agree that the likelihood of FDA approval is imminent but the question is will it get orphan status. That's the key thing, imho.
Again, BMSN's destiny is based on what the FDA decides not on what posters on a message board say and do.
If there is any manipulation of BMSN, which I agree can easily be done due to it being a penny stock, it's been clearly focused on the range i previously mentioned.
Until then we wait for the FDA decision to either give credibility to the science you believe in or to further erode BMSN's PPS into bankruptcy if it can't recover from FDA denial.
I think we both agree that the likelihood of FDA approval is imminent but the question is will it get orphan status. That's the key thing, imho.
(0)
(0)Scroll down for more posts ▼
